Our Mission: Stronger Evidence

ObvioHealth is on a mission to conduct innovative and efficient trials that deliver stronger evidence for better health outcomes. We use technology to develop more precise and accessible measurement tools to capture more robust and accurate data—so life-improving innovations can get to market faster.

“I have been struck again and again by how important measurement is to improving the human condition."

Bill Gates

Our Difference: Tech and Team

Our success comes from the fusion of experienced clinical researchers and pioneering health technology.

ObvioGo® DCT Platform and App

Powerful, flexible technology to capture and unify more accurate multi-source data.

Virtual Site (COACH) Team

Personalized human connection to boost compliance and retention.

DCT Consulting and CRO Services

Expertise to design and conduct studies from start to finish.

Digital Instruments and Endpoint Expertise

The right tools, outcomes, and endpoints to power studies and deliver stronger evidence.

ObvioHealth in Numbers

ObvioHealth has been innovating clinical trials since 2017, when we launched one of the first-ever DCT platforms with a mobile app. Today, we are an industry leader, designing and running DCTs across the globe that generate more robust and accurate data.


Countries with Studies


Therapeutic Areas


ePRO Compliance




Faster Recruitment


Days to Database Lock
Co-creating the future of clinical trials with these industry leaders.

Meet Our Leadership

Ivan Jarry

Chief Executive Officer

Matty Lynch

Chief Operations Officer

Craig Gravina

Chief Technology Officer

Scott Dixon

Chief Commercial Officer

Leslie Pascaud

Chief Marketing Officer

Cheryl Walter

Chief Talent Officer

James Hendrick

Sr. VP, Global Commercial Operations

Our Strategic Partners

Our Story: DCT is in Our DNA

We were purpose-built from the ground up to conduct decentralized clinical trials.


Company Launch


Development of patient-facing mobile app


Completion of first virtual trial in APAC


Launch of Obvio-19, a remote COVID-19 registry
Completion of first virtual trial in dermatology
Strategic alliance signed with IQVIA


Completion of the world’s first fully virtual urogynecology study
Completion of first COVID-19 interventional study with device integration
RWE partnership agreement signed with Dedalus
Partnership signed with Novotech


Launch of ObvioGo®, our next-generation, configurable DCT platform
Collaboration agreement signed with Oracle
Launch of first fully virtual DTx study for migraines

Meet our Advisory Board

Susan Dallabrida, PhD


Expert in improving data quality and outcomes optimization for clinical trials. CEO of SPRIM Consultancy, with previous positions at Oracle, ERT, PHT and Biogen.

Bill Taaffe


Recognized leader in pharmaceutical and CRO industries. Former President and Chief Executive Officer, North America of ICON Clinical Research.

Donna Reed


Expert in the ePRO and eCOA, Lead eCOA solutions at ERT, with previous positions at PHT, Covance and Genelabs Diagnostics.

Graham Bunn


Expert in clinical information technology. Founder and executive consultant of eClinical Edge, formerly Global Vice-President of Partnerships at Medidata, with previous experience at Parexel International, IQVIA and Clinsoft.

Nelly Conus


Expert in scientific R&D innovation. Currently DigitalSolutions Consultant for Patient-Centric Remote Trials at Novartis, ObvioHealth, Glaxo SmithKline and Nestle.

Steve Heath


Expert in eClincial technology trends. Formerly Chief Commercial Officer of Trial Grid and Vice President of Global Partner Business at Medidata.

Sunil Joshi


Expert in drug development and commercialization strategy  Former head of Strategy & Cell Therapy Unit for Oncology at Bayer, with previous experience at BMS, Onyx and Halozyme.

Awards and Recognition

Everest PEAK Matrix®

Inc. 5000 (2x)

Reuters Finalist—Most Valuable Clinical Technology

Scrip Shortlist 

CB News Shortlist  

Our Current Trials

With a growing list of trials scheduled for launch in 2023, we are constantly innovating to find ways to further reduce patient burden while increasing data accuracy across a range of therapeutic areas.

Work for Us

Remote and hybrid positions, unlimited PTO, and company stock grants are just a few benefits of working for ObvioHealth.